Evidence map›Paper›PMID 37323424›Full record

ArticleOpen forum infectious diseases2023

Charlotte Wigston, Melanie Lavender, Rebecca Long, Dipen Sankhesara, David Ching, Graham Weaire-Buchanan, Shakeel Mowlaboccus, Geoffrey W Coombs, Kaitlyn Lam, Jeremy Wrobel and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Therapeutic advances in infectious disease
    Article
  9. Outcomes of a Routine Screening Protocol to Prevent Metamycoplasma and Ureaplasma Infection in Lung Transplant Recipients.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Charlotte WigstonAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.ORCID https://orcid.org/0000-0002-3877-4314
Melanie LavenderAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Rebecca LongAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Dipen SankhesaraAdvanced Heart Failure Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
David ChingAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Graham Weaire-BuchananDepartment of Microbiology, PathWest Laboratory Medicine Western Australia, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Shakeel MowlaboccusDepartment of Microbiology, PathWest Laboratory Medicine Western Australia, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Geoffrey W CoombsDepartment of Microbiology, PathWest Laboratory Medicine Western Australia, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Kaitlyn LamAdvanced Heart Failure Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Jeremy WrobelAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Meow Cheong YawAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Michael MuskAdvanced Lung Disease Unit, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Peter BoanDepartment of Microbiology, PathWest Laboratory Medicine Western Australia, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.ORCID https://orcid.org/0000-0002-0518-0421
Fiona Stanley Hospital · AUMurdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperammonemia syndrome (HS) is a life-threatening condition occurring in solid organ transplant patients, affecting primarily lung recipients, and is associated with

Indexed as

donor-derived infectionhyperammonemiaMycoplasmatransplantationUreaplasma

Identifiers

PMID37323424
PMCPMC10264062
OpenAlexW4377115643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.